Capricor Therapeutics, Inc.
CAPR
$26.01
-$0.15-0.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.50% | -22.79% | 5.17% | -6.23% | -242.74% |
| Total Depreciation and Amortization | 6.39% | 1.60% | 1.73% | 19.93% | 7.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.67% | 65.67% | 20.69% | -38.19% | 145.51% |
| Change in Net Operating Assets | -76.46% | -20,405.26% | -99.66% | -85.68% | 211.79% |
| Cash from Operations | -24.14% | -19.70% | 2.15% | -212.77% | 56.52% |
| Capital Expenditure | -109.71% | -27.82% | -176.57% | -27.13% | -55.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -398.46% | 141.54% | 24.76% | -36.08% | 120.41% |
| Cash from Investing | -458.89% | 170.13% | 9.63% | -39.10% | 119.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.41% | 3,554,405.71% | -64.29% | -61.11% | -99.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.41% | 3,554,405.71% | -64.29% | -61.11% | -99.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -167.98% | 7,292.48% | 32.82% | -131.72% | 130.67% |